|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University Hospital, Ghent |
|---|---|
| Information provided by: | University Hospital, Ghent |
| ClinicalTrials.gov Identifier: | NCT00228332 |
Purpose
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
| Condition | Intervention | Phase |
|---|---|---|
|
Verrucae Vulgares |
Drug: Administration of zinkgluconaat or placebo |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
| Official Title: | A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares |
| Estimated Enrollment: | 70 |
| Study Start Date: | April 2004 |
| Study Completion Date: | March 2006 |
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: - Patients with verrucae vulgares Exclusion Criteria:
Contacts and Locations More Information
| Study ID Numbers: | 2004/005 |
| Study First Received: | September 13, 2005 |
| Last Updated: | December 19, 2007 |
| ClinicalTrials.gov Identifier: | NCT00228332 History of Changes |
| Health Authority: | Belgium: Institutional Review Board |
|
Virus Diseases Skin Diseases, Infectious Warts |
Skin Diseases DNA Virus Infections Papillomavirus Infections |
|
Skin Diseases, Viral Virus Diseases Skin Diseases, Infectious Neoplasms Warts |
Skin Diseases Tumor Virus Infections DNA Virus Infections Papillomavirus Infections |
